Search research articles
Contact Us
Filters
Showing results (91-100 of 107) with videos related to
Page
of 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 23, 2006
Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia Group
Lionel Adès, Sylvie Chevret, Emmanuel Raffoux, et al.
American Journal of Hematology
|
April 9, 2013
Long-term follow-up of European APL 2000 trial, evaluating the role of cytarabine combined with ATRA and Daunorubicin in the treatment of nonelderly APL patients
Lionel Adès, Sylvie Chevret, Emmanuel Raffoux, et al.
Oncotarget
|
May 18, 2017
BCL2L10 positive cells in bone marrow are an independent prognostic factor of azacitidine outcome in myelodysplastic syndrome and acute myeloid leukemia
Valérie Vidal, Guillaume Robert, Laure Goursaud, et al.
Nature Medicine
|
October 21, 2003
PML-RARA-targeted DNA vaccine induces protective immunity in a mouse model of leukemia
Rose Ann Padua, Jerome Larghero, Marie Robin, et al.
Leukemia Research
|
November 17, 2012
Localization of the NRAS:BCL-2 complex determines anti-apoptotic features associated with progressive disease in myelodysplastic syndromes
Carole Le Pogam, Patricia Krief, Stephanie Beurlet, et al.
Blood
|
May 20, 2006
High molecular response rate of polycythemia vera patients treated with pegylated interferon alpha-2a
Jean-Jacques Kiladjian, Bruno Cassinat, Pascal Turlure, et al.
Plos One
|
March 31, 2015
Comparison of newly diagnosed and relapsed patients with acute promyelocytic leukemia treated with arsenic trioxide: insight into mechanisms of resistance
Ezhilarasi Chendamarai, Saravanan Ganesan, Ansu Abu Alex, et al.
Nature Reviews. Cancer
|
October 12, 2012
Cancer stem cell definitions and terminology: the devil is in the details
Peter Valent, Dominique Bonnet, Ruggero De Maria, et al.
The New England Journal of Medicine
|
April 15, 2005
DNA topoisomerase II in therapy-related acute promyelocytic leukemia
Anita R Mistry, Carolyn A Felix, Ryan J Whitmarsh, et al.
Cancer Research
|
December 20, 2007
BCL-2 and mutant NRAS interact physically and functionally in a mouse model of progressive myelodysplasia
Nader Omidvar, Scott Kogan, Stephanie Beurlet, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 107) with videos related to
Sort By:
Page
of 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 23, 2006
Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia Group
Lionel Adès, Sylvie Chevret, Emmanuel Raffoux, et al.
American Journal of Hematology
|
April 9, 2013
Long-term follow-up of European APL 2000 trial, evaluating the role of cytarabine combined with ATRA and Daunorubicin in the treatment of nonelderly APL patients
Lionel Adès, Sylvie Chevret, Emmanuel Raffoux, et al.
Oncotarget
|
May 18, 2017
BCL2L10 positive cells in bone marrow are an independent prognostic factor of azacitidine outcome in myelodysplastic syndrome and acute myeloid leukemia
Valérie Vidal, Guillaume Robert, Laure Goursaud, et al.
Nature Medicine
|
October 21, 2003
PML-RARA-targeted DNA vaccine induces protective immunity in a mouse model of leukemia
Rose Ann Padua, Jerome Larghero, Marie Robin, et al.
Leukemia Research
|
November 17, 2012
Localization of the NRAS:BCL-2 complex determines anti-apoptotic features associated with progressive disease in myelodysplastic syndromes
Carole Le Pogam, Patricia Krief, Stephanie Beurlet, et al.
Blood
|
May 20, 2006
High molecular response rate of polycythemia vera patients treated with pegylated interferon alpha-2a
Jean-Jacques Kiladjian, Bruno Cassinat, Pascal Turlure, et al.
Plos One
|
March 31, 2015
Comparison of newly diagnosed and relapsed patients with acute promyelocytic leukemia treated with arsenic trioxide: insight into mechanisms of resistance
Ezhilarasi Chendamarai, Saravanan Ganesan, Ansu Abu Alex, et al.
Nature Reviews. Cancer
|
October 12, 2012
Cancer stem cell definitions and terminology: the devil is in the details
Peter Valent, Dominique Bonnet, Ruggero De Maria, et al.
The New England Journal of Medicine
|
April 15, 2005
DNA topoisomerase II in therapy-related acute promyelocytic leukemia
Anita R Mistry, Carolyn A Felix, Ryan J Whitmarsh, et al.
Cancer Research
|
December 20, 2007
BCL-2 and mutant NRAS interact physically and functionally in a mouse model of progressive myelodysplasia
Nader Omidvar, Scott Kogan, Stephanie Beurlet, et al.
Page
of 11